Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison.
about
Protons, Photons, and the Prostate - Is There Emerging Evidence in the Ongoing Discussion on Particle Therapy for the Treatment of Prostate Cancer?Proton beam therapy: clinical utility and current status in prostate cancerProton therapy for early stage prostate cancer: is there a case?Found in translation: Integrating laboratory and clinical oncology researchUncertainty incorporated beam angle optimization for IMPT treatment planning.Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancer.Risk of secondary malignant neoplasms from proton therapy and intensity-modulated x-ray therapy for early-stage prostate cancerPromise and pitfalls of heavy-particle therapy.Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer.Interfractional variations in the setup of pelvic bony anatomy and soft tissue, and their implications on the delivery of proton therapy for localized prostate cancer.Proton energy optimization and reduction for intensity-modulated proton therapyA beam-specific planning target volume (PTV) design for proton therapy to account for setup and range uncertainties.Proton versus intensity-modulated radiotherapy for prostate cancer: patterns of care and early toxicity.Proton-based radiotherapy for unresectable or incompletely resected osteosarcoma.Patient Specific Characteristics Are an Important Factor That Determines the Risk of Acute Grade ≥ 2 Rectal Toxicity in Patients Treated for Prostate Cancer with IMRT and Daily Image Guidance Based on Implanted Gold Markers.Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer.Does radical treatment have a role in the management of low-risk prostate cancer? The place for brachytherapy and external beam radiotherapy.Enhanced antitumor effect of combined gemcitabine and proton radiation in the treatment of pancreatic cancer.Proton radiation for localized prostate cancer.Technological advances in radiation therapy for prostate cancer.Comparative effectiveness research for prostate cancer radiation therapy: current status and future directions.Clinical controversies: proton therapy for prostate cancer.Proton beam therapy and localised prostate cancer: current status and controversiesProton beam radiation therapy for prostate cancer-is the hype (and the cost) justified?Proton beam and prostate cancer: An evolving debate.Progress and controversies: Radiation therapy for prostate cancer.Evaluation of the dosimetric impact of interfractional anatomical variations on prostate proton therapy using daily in-room CT images.Radiation-induced erectile dysfunction: Recent advances and future directions.Investigating deformable image registration and scatter correction for CBCT-based dose calculation in adaptive IMPT.Point/Counterpoint. Within the next 10-15 years protons will likely replace photons as the most common type of radiation for curative radiotherapy.Maximizing the biological effect of proton dose delivered with scanned beams via inhomogeneous daily dose distributions.A method for evaluation of proton plan robustness towards inter-fractional motion applied to pelvic lymph node irradiation.Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases.Improved beam angle arrangement in intensity modulated proton therapy treatment planning for localized prostate cancerA comparison of the dose distributions from three proton treatment planning systems in the planning of meningioma patients with single-field uniform dose pencil beam scanning.Hypofractionated proton therapy for prostate cancer: dose delivery uncertainty due to interfractional motion.Hypofractionated proton boost combined with external beam radiotherapy for treatment of localized prostate cancer.AMBIENT DOSE EQUIVALENT VERSUS EFFECTIVE DOSE FOR QUANTIFYING STRAY RADIATION EXPOSURES TO A PATIENT RECEIVING PROTON THERAPY FOR PROSTATE CANCER.Dosimetric and radiobiological impact of intensity modulated proton therapy and RapidArc planning for high-risk prostate cancer with seminal vesicles.The effects of motion on the dose distribution of proton radiotherapy for prostate cancer.
P2860
Q26767399-E0B43505-9DAD-463D-ACFD-81FBC64C5FF8Q28070150-8CB48767-4483-40C0-8F0E-7416CDF39E34Q28072657-442C78FD-C622-40EE-B84E-95CE5152D939Q28744471-B055164C-D7FA-418B-A1DB-C9AF663C01A9Q33274545-E373B18F-878A-4ADB-A310-57B1479C5A6CQ33919002-8FB8E542-E359-4451-A519-2FDF5579E1EDQ33998022-80F34B1B-6011-4E95-B014-152F227AB3E9Q34124263-1C1A52C7-A69A-4AC6-9B96-52E570BCC19BQ34268907-8A2CC2E7-E88F-4103-8AEA-283B510AFAA5Q34520588-94B21C26-F4FA-4657-B48F-FA37B6754651Q35212130-6FAE47E6-82B8-4138-A434-5238D632670AQ35243057-CF8F990E-4C0B-4837-A489-608BBF6B40D7Q36507549-8F41FA97-6335-48B0-8308-586C92BB3209Q37026245-5391D438-FB43-446E-8B16-A763F26EDF62Q37138297-0E5BCFDB-69D0-4DCE-A91E-D47EF79BCEDDQ37139334-BEFF5020-9D2C-4504-AF3A-4672BAED0DA7Q37262835-B907FC3A-B5C4-4E2C-A0A1-232F1AE3980CQ37440160-5602F4D5-71B6-46C1-A737-6B66F550D284Q37478108-5860E5EB-7578-4A02-AE5C-97A6FE590302Q37738793-0E99DB60-8501-41B8-A22F-C2322DAAB364Q37965553-B965E4EB-9F76-453F-AC9E-A20B15CE6501Q38087711-F23BACED-B65C-4C1A-B7AD-9502FDCC7A96Q38088468-8CB12FA4-6B40-4EC3-9B39-F08E546A6214Q38095001-32C7429B-1FF4-4E83-9A72-E43B99967CD6Q38177807-C3B97424-3043-4E55-97C4-F5BD968B2557Q38252429-419125C4-0966-4BD6-A251-AEFAE0D9A026Q38260064-3C0D711E-FB46-4742-92B4-59DD3E645BFFQ38652305-F50848DD-BE33-4ED2-8706-35DC3BD90F96Q39248664-17FFB3D3-6FAB-4C28-947A-ADA6C568F6ECQ40031228-900C9CAF-9397-4E22-8AB9-A791CF033FF8Q40625237-111B9D1F-4AFA-47A1-9CDE-10AFAA1B8512Q40704389-8E471545-5412-4906-9284-24E83D789961Q41198833-413DF631-39F6-4360-892B-F716CBE39FEAQ41416202-3EC591C3-9A8D-4DC1-B907-69F0AA173782Q41440121-92835C42-E2F5-4921-8CA9-72940C857B8CQ41497799-58B2A72D-042A-494A-B961-79DE4EADAE66Q42045691-A934FA5B-2CFE-4818-BCC8-0C8CC6216CC2Q42153462-0681F00B-F3F0-40A6-841F-37D3511FC79CQ42315718-03C8C226-1098-42D6-A3D0-A144315B56A0Q42506349-D9B98CD0-3EBC-4867-9C39-9A323C8C12AD
P2860
Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Radiotherapy treatment of earl ...... treatment planning comparison.
@en
type
label
Radiotherapy treatment of earl ...... treatment planning comparison.
@en
prefLabel
Radiotherapy treatment of earl ...... treatment planning comparison.
@en
P2093
P2860
P1476
Radiotherapy treatment of earl ...... treatment planning comparison
@en
P2093
Alexei Trofimov
Anthony L Zietman
John J Coen
Judith A Adams
Karen P Doppke
Paul L Nguyen
Thomas F Delaney
Thomas R Bortfeld
William U Shipley
P2860
P304
P356
10.1016/J.IJROBP.2007.03.018
P407
P577
2007-05-21T00:00:00Z